Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
softwave
Press Release
May 4, 2023
Chris Holt Takes the Helm as New CEO of SoftWave Tissue Regeneration Technologies, Ushering in a New Era of Growth
Amazon Healthcare veteran Chris Holt brings experience and a bold vision to lead SoftWave TRT's market expansion and product innovation efforts.
Read More
Press Release
Dec 22, 2021
SoftWave Tissue Regeneration Technologies Enters Exclusive Distribution Agreement With Cynosure to Sell Technology in the Aesthetics and Sexual Health Markets
Exclusive North American Agreement
Read More
Press Release
May 19, 2021
SoftWave Tissue Regeneration Technologies Receives FDA Clearance for Blood Circulation Increase, Minor Aches and Pains Relief and Connective Tissue Activation
Extracorporeal shock wave device offers healthcare professionals another treatment option
Read More
Press Release
Sep 1, 2020
SoftWave® Tissue Regeneration Technologies Receives FDA Clearance for the Treatment of Burn Wounds
Read More
Press Release
Aug 19, 2020
Softwave® Tissue Regeneration Technologies Announces Landmark Trial for Acute Traumatic Spinal Cord Injuries
Read More
Press Release
Aug 6, 2020
SoftWave Tissue Regeneration Technologies Announces Plan for Cellulite Trial
Read More
Press Release
Apr 11, 2020
TISSUE REGENERATION TECHNOLOGIES Announces That Its First Coronavirus Clinical Trial Has Been Initiated Utilizing Unfocused Shockwave Therapy (SoftWaves®)
Additionally, TRT has filed a second patent in the war Against COVID 19. The patent is for the treatment of lung (and other organ) disorders and diseases such as COVID-19 and COPD with shockwaves to treat the virus and avert mortality in order to accelerate the recovery of afflicted patients.
Read More
First
Prev
1
Next
Last
